Artelo Biosciences Inc ARTL 深 沪
等待开盘 06-26 09:30:00 美东时间
1.1501
-0.010
-0.85%
华盛通- 最 高1.2923
- 今 开1.16
- 成交量 11.83万股
- 最 低 1.12
- 昨 收 1.16
- 总市值 4.90万
- 52周最高 28.60
- 市盈率 静 --
- 换手率 277.76%
- 52周最低 1.05
- 委 比 98.74%
- 总股本 4.26万
- 历史最高 28.60
- 量 比 0.65
- 振 幅 14.85%
- 历史最低 0.26
- 每 手 1
- 风险率 4.46%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why JOYY Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Gainers: PHGE +97.3%, ARTL +74.8%, QTEX +52.4%, MNTX +34.4%, HLIT +28.3%, WOK +25%, CPSH +24.7%, CODX +22.7%, MDAI +22%. Losers: AKTX -25.2%, RYOJ -18.6%, DEVS -18.6%, AKAN -17%, ADTX -16.3%, LFS -15.6%
05-26 18:00
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 635.6% to $2.0...
05-18 20:05
Crude Oil Surges 4%; US Consumer Sentiment Declines In March
U.S. stocks down, NASDAQ drops 1.5% on Friday. Energy shares up, consumer discretionary down. University of Michigan's Consumer Sentiment Index falls.
03-28 00:40
Artelo Biosciences Stock Soars After Withdrawing SEC Filing
Artelo Biosciences Inc. shares are trading higher Friday after withdrawing its SEC Registration Statement, citing no plan to sell securities.
03-27 21:36
Artelo Biosciences Expands Into $16.3B Glaucoma Market Via Investigator‑Sponsored Study, Underscoring Multi‑Platform Pipeline Durability Across High‑Value Therapeutic Areas
Artelo Biosciences, Inc. (NASDAQ:ARTL) is drawing increased attention following its expansion into the $16.3 billion glaucoma market through a fully funded investigator-sponsored clinical study—an announcement that
03-25 19:34
Why Keysight Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Shares of Keysight Technologies Inc (NYSE:KEYS) rose sharply in pre-market trad...
02-24 18:21
Artelo Biosciences Has Been Granted European Patent Number EP4259111 Titled "PHARMACEUTICAL COMPOSITIONS COMPRISING CANNABINOID AGONIST"
https://register.epo.org/application?number=EP21827629
2025-12-02 04:58
Maxim Group Downgrades Artelo Biosciences to Hold
Maxim Group analyst Jason McCarthy downgrades Artelo Biosciences (NASDAQ:ARTL) from Buy to Hold.
2025-11-19 23:48
Artelo Biosciences Announces Reverse Stock Split
Artelo Biosciences approves a 6-for-1 reverse stock split effective June 13, 2025, to increase share price and meet NASDAQ listing requirements.
2025-06-11 12:30
